Amneal Pharmaceuticals (AMRX) Short Interest Ratio & Short Volume $8.47 -0.53 (-5.89%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Amneal Pharmaceuticals Short Interest DataAmneal Pharmaceuticals (AMRX) has a short interest of 3.50 million shares, representing 2.92% of the float (the number of shares available for trading by the public). This marks a -16.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.9, indicating that it would take 2.9 days of the average trading volume of 1.41 million shares to cover all short positions.Current Short Interest3,500,000 sharesPrevious Short Interest4,180,000 sharesChange Vs. Previous Month-16.27%Dollar Volume Sold Short$29.65 millionShort Interest Ratio2.9 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares309,540,000 sharesFloat Size119,850,000 sharesShort Percent of Float2.92%Today's Trading Volume1,623,743 sharesAverage Trading Volume1,409,349 sharesToday's Volume Vs. Average115% Short Selling Amneal Pharmaceuticals? Sign up to receive the latest short interest report for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAMRX Short Interest Over TimeAMRX Days to Cover Over TimeAMRX Percentage of Float Shorted Over Time Ad WealthPressThe Tesla Trade Is Back In BusinessIf you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Amneal Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20243,500,000 shares $29.65 million -16.3%2.9%2.9 $8.47 10/15/20244,180,000 shares $36.83 million -7.7%3.5%3.4 $8.81 9/30/20244,530,000 shares $37.69 million -2.4%3.8%3.5 $8.32 9/15/20244,640,000 shares $40.00 million +8.7%3.9%3.2 $8.62 8/31/20244,270,000 shares $36.98 million +0.2%3.6%2.9 $8.66 8/15/20244,260,000 shares $33.70 million -4.1%3.6%2.9 $7.91 Get the Latest News and Ratings for AMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/20244,440,000 shares $32.55 million -3.3%4.0%3.1 $7.33 7/15/20244,590,000 shares $33.87 million +1.6%4.1%3 $7.38 6/30/20244,520,000 shares $28.70 million +24.9%4.1%2.9 $6.35 6/15/20243,620,000 shares $24.94 million +0.3%3.3%2.4 $6.89 5/31/20243,610,000 shares $24.11 million +17.6%3.3%2.3 $6.68 5/15/20243,070,000 shares $21.09 million +29.5%2.8%1.9 $6.87 4/30/20242,370,000 shares $14.34 million -15.4%2.3%1.5 $6.05 4/15/20242,800,000 shares $15.51 million +16.7%2.5%1.8 $5.54 3/31/20242,400,000 shares $14.54 million +15.9%2.2%1.6 $6.06 3/15/20242,070,000 shares $11.39 million +13.1%1.9%1.4 $5.50 2/29/20241,830,000 shares $10.10 million -12.9%1.7%1.2 $5.52 2/15/20242,100,000 shares $12.37 million -17.3%1.9%1.5 $5.89 1/31/20242,540,000 shares $13.59 million +1.6%2.3%1.9 $5.35 12/15/20232,650,000 shares $13.75 million -16.7%2.4%1.9 $5.19 11/30/20233,180,000 shares $13.71 million -12.2%5.8%2.5 $4.31 11/15/20233,620,000 shares $16.25 million +13.5%6.5%2.9 $4.49 10/31/20233,190,000 shares $12.33 million +4.3%3.1%2.6 $3.87 10/15/20233,060,000 shares $11.75 million -20.5%3.0%2.4 $3.84 9/30/20233,850,000 shares $16.25 million +4.3%3.7%3.4 $4.22 9/15/20233,690,000 shares $15.17 million +1.9%3.6%3.4 $4.11 8/31/20233,620,000 shares $14.81 million +3.7%3.5%3.1 $4.09 8/15/20233,490,000 shares $13.66 million -3.6%3.4%3 $3.92 7/31/20233,620,000 shares $11.58 million -12.8%3.6%3.3 $3.20 7/15/20234,150,000 shares $12.57 million +0.2%4.1%4 $3.03 6/30/20234,140,000 shares $12.83 million -4.6%4.1%3.9 $3.10 6/15/20234,340,000 shares $11.72 million -13.6%4.3%4.4 $2.70 5/31/20235,020,000 shares $11.75 million +7.3%4.9%5.3 $2.34 5/15/20234,680,000 shares $9.45 million -24.8%4.6%4.9 $2.02 4/30/20236,220,000 shares $12.00 million -9.9%6.3%6.2 $1.93 4/15/20236,900,000 shares $9.38 million +7.1%6.9%6.3 $1.36 3/31/20236,440,000 shares $8.95 million -13.1%6.5%6.1 $1.39 3/15/20237,410,000 shares $10.08 million +4.1%8.9%6.6 $1.36 2/28/20237,120,000 shares $14.67 million -11.7%7.2%5.5 $2.06 2/15/20238,060,000 shares $20.23 million -11.5%8.1%6.6 $2.51The only candlestick pattern worth a darn (Ad)It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up… 1/31/20239,110,000 shares $20.04 million +10.6%9.1%7.1 $2.20 1/15/20238,240,000 shares $18.29 million +6.5%8.3%7.1 $2.22 12/30/20227,740,000 shares $15.40 million +142.6%7.8%6.8 $1.99 12/15/20223,190,000 shares $7.24 million -12.6%3.3%2.9 $2.27 11/30/20223,650,000 shares $9.34 million -15.3%3.8%3.5 $2.56 11/15/20224,310,000 shares $9.91 million -7.9%4.5%4.4 $2.30 10/31/20224,680,000 shares $10.30 million -2.9%4.8%4 $2.20 10/15/20224,820,000 shares $9.45 million +2.6%5.0%4.3 $1.96 9/30/20224,700,000 shares $9.49 million +2.2%4.8%4.3 $2.02 9/15/20224,600,000 shares $10.81 million +15.3%4.7%4.3 $2.35 8/31/20223,990,000 shares $8.66 million +7.3%4.1%3.9 $2.17 8/15/20223,720,000 shares $11.87 million +9.4%3.8%4.1 $3.19 7/31/20223,400,000 shares $12.04 million -6.6%3.5%4.9 $3.54 7/15/20223,640,000 shares $11.39 million -3.7%3.8%5.3 $3.13 6/30/20223,780,000 shares $12.02 million -9.1%3.9%5.1 $3.18 6/15/20224,160,000 shares $13.98 million -1.0%4.6%5.6 $3.36 5/31/20224,200,000 shares $15.25 million +7.7%4.4%5.6 $3.63 5/15/20223,900,000 shares $13.46 million +3.7%4.0%5.1 $3.45 4/30/20223,760,000 shares $14.51 million +10.3%3.9%5 $3.86 4/15/20223,410,000 shares $14.05 million +6.9%3.5%5 $4.12 3/31/20223,190,000 shares $13.30 million -0.9%3.3%5 $4.17 3/15/20223,220,000 shares $12.78 million +9.9%3.4%4.9 $3.97 2/28/20222,930,000 shares $13.27 million +1.0%3.1%4.5 $4.53 2/15/20222,900,000 shares $13.72 million +30.0%3.0%4.4 $4.73 1/31/20222,230,000 shares $9.88 million +4.7%2.3%3.2 $4.43 1/15/20222,130,000 shares $9.88 million -19.3%2.2%2.8 $4.64 12/31/20212,640,000 shares $12.65 million -6.7%2.8%3.4 $4.79 12/15/20212,830,000 shares $11.72 million +8.0%3.0%3.4 $4.14 11/30/20212,620,000 shares $10.95 million -15.2%2.7%3.1 $4.18 11/15/20213,090,000 shares $15.94 million -3.7%3.2%3.1 $5.16 10/29/20213,210,000 shares $17.62 million -5.3%3.4%3.1 $5.49 10/15/20213,390,000 shares $19.12 million -5.8%3.5%3.5 $5.64 9/30/20213,600,000 shares $19.22 million -10.9%3.8%3.3 $5.34 9/15/20214,040,000 shares $20.00 million -9.2%4.2%3.7 $4.95 8/31/20214,450,000 shares $25.10 million -2.4%4.7%4.3 $5.64 8/13/20214,560,000 shares $23.30 million -4.4%4.8%5.7 $5.11 7/30/20214,770,000 shares $23.52 million -0.6%5.0%5.6 $4.93 7/15/20214,800,000 shares $20.93 million +12.4%5.0%5.4 $4.36 6/30/20214,270,000 shares $21.86 million -5.3%4.5%5 $5.12 6/15/20214,510,000 shares $25.71 million -0.4%4.7%4.8 $5.70 5/28/20214,530,000 shares $25.64 million +2.0%4.8%3.7 $5.66 5/14/20214,440,000 shares $24.33 million -31.2%4.7%2.3 $5.48 4/30/20216,450,000 shares $36.57 million +57.7%6.8%3.2 $5.67 4/15/20214,090,000 shares $23.80 million +29.4%4.3%2 $5.82 3/31/20213,160,000 shares $21.05 million -43.6%3.3%1.5 $6.66 3/15/20215,600,000 shares $33.71 million +2.8%5.9%2.8 $6.02 2/26/20215,450,000 shares $26.65 million -9.9%5.8%3.1 $4.89 2/12/20216,050,000 shares $35.70 million +21.2%6.4%5.1 $5.90 1/29/20214,990,000 shares $24.60 million -18.1%5.3%4.2 $4.93 1/15/20216,090,000 shares $29.54 million +19.4%6.4%5.2 $4.85Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide 12/31/20205,100,000 shares $23.46 million -21.9%5.4%4.3 $4.60 12/15/20206,530,000 shares $28.67 million +2.5%6.9%5.7 $4.39 11/30/20206,370,000 shares $25.93 million -3.6%6.7%5.5 $4.07 11/15/20206,610,000 shares $27.37 million +7.0%7.0%5.6 $4.14 10/30/20206,180,000 shares $26.94 million -1.3%6.5%5.4 $4.36 10/15/20206,260,000 shares $30.61 million -12.7%6.6%5.5 $4.89 9/30/20207,170,000 shares $27.82 million -4.5%7.6%6.3 $3.88 9/15/20207,510,000 shares $30.34 million +8.7%8.0%6.4 $4.04 8/31/20206,910,000 shares $28.40 million -0.1%7.3%5.5 $4.11 8/14/20206,920,000 shares $29.41 million -3.4%7.3%4.9 $4.25 7/31/20207,160,000 shares $31.00 million +2.6%7.6%4.2 $4.33 7/15/20206,980,000 shares $32.60 million -5.6%7.4%4.2 $4.67 6/30/20207,390,000 shares $35.18 million +26.8%7.8%4.3 $4.76 6/15/20205,830,000 shares $25.42 million -4.3%6.2%3 $4.36 5/29/20206,090,000 shares $29.48 million -9.2%6.5%2.8 $4.84 5/15/20206,710,000 shares $27.65 million No Change7.1%3 $4.12 4/30/20206,710,000 shares $24.36 million +4.7%7.1%3.2 $3.63 4/15/20206,410,000 shares $21.54 million +2.9%6.8%3.5 $3.36 3/31/20206,230,000 shares $19.94 million +17.6%6.6%3.3 $3.20 3/13/20205,296,700 shares $17.59 million +20.7%4.7%2 $3.32 2/28/20204,390,000 shares $16.73 million +20.3%4.9%1.6 $3.81 2/14/20203,650,000 shares $11.61 million -7.4%4.4%1.3 $3.18 1/31/20203,940,000 shares $15.17 million -27.3%4.8%1.4 $3.85 1/15/20205,420,000 shares $27.32 million +9.3%6.6%1.8 $5.04 12/31/20194,960,000 shares $23.46 million -13.9%6.0%1.7 $4.73 AMRX Short Interest - Frequently Asked Questions What is Amneal Pharmaceuticals' current short interest? Short interest is the volume of Amneal Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 3,500,000 shares of AMRX short. 2.92% of Amneal Pharmaceuticals' shares are currently sold short. Learn More on Amneal Pharmaceuticals' current short interest. What is a good short interest ratio for Amneal Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMRX shares currently have a short interest ratio of 3.0. Learn More on Amneal Pharmaceuticals's short interest ratio. What is a good short interest percentage for Amneal Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.92% of Amneal Pharmaceuticals' floating shares are currently sold short. Is Amneal Pharmaceuticals' short interest increasing or decreasing? Amneal Pharmaceuticals saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 3,500,000 shares, a drop of 16.3% from the previous total of 4,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Amneal Pharmaceuticals' float size? Amneal Pharmaceuticals currently has issued a total of 309,540,000 shares. Some of Amneal Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amneal Pharmaceuticals currently has a public float of 119,850,000 shares. How does Amneal Pharmaceuticals' short interest compare to its competitors? 2.92% of Amneal Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Amneal Pharmaceuticals: Amphastar Pharmaceuticals, Inc. (12.16%), Perrigo Company plc (3.64%), Collegium Pharmaceutical, Inc. (19.87%), Foghorn Therapeutics Inc. (3.93%), Qiagen (1.61%), Revolution Medicines, Inc. (10.78%), Intra-Cellular Therapies, Inc. (2.23%), Roivant Sciences Ltd. (12.38%), Lantheus Holdings, Inc. (6.03%), Legend Biotech Co. (8.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Amneal Pharmaceuticals stock? Short selling AMRX is an investing strategy that aims to generate trading profit from Amneal Pharmaceuticals as its price is falling. AMRX shares are trading down $0.53 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amneal Pharmaceuticals? A short squeeze for Amneal Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AMRX, which in turn drives the price of the stock up even further. How often is Amneal Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMRX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Amphastar Pharmaceuticals Short Interest Data Perrigo Short Interest Data Collegium Pharmaceutical Short Interest Data Foghorn Therapeutics Short Interest Data Qiagen Short Interest Data Revolution Medicines Short Interest Data Intra-Cellular Therapies Short Interest Data Roivant Sciences Short Interest Data Lantheus Short Interest Data Legend Biotech Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMRX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amneal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMRX Stock Alerts